✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Aarti Drugs Ltd.

AARTIDRUGS

Market Cap
₹3,331 Cr.
P/E
21.82

Aarti Drugs Ltd.

  • Aarti Drugs
  • Morepen Laboratories
  • Solara Active Pharma
  • TJI Pharma - Small Cap
FAQs on Aarti Drugs Ltd. Shareprice

Aarti Drugs has given lower returns compared to its competitors.
Aarti Drugs has grown at ~15.2% over the last 6yrs while peers have grown at a median rate of 21.2%

Aarti Drugs is not expensive.
Latest PE of Aarti Drugs is 21.82, while 3 year average PE is 26.94.
Also latest EV/EBITDA of Aarti Drugs is 13.97 while 3yr average is 15.49.

View FAQ's On Business
Growth Table
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Balance Sheet
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Cash Flow
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Quarterly Results
  • Aarti Drugs Ltd.
  • Morepen Laboratories
  • Solara Active Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Aarti Drugs Ltd. Financials

Balance sheet of Aarti Drugs is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Aarti Drugs is increasing.
Latest debt of Aarti Drugs is ₹574 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹546 Crs.

The profit is oscillating.
The profit of Aarti Drugs is ₹153 Crs for TTM, ₹171 Crs for Mar 2024 and ₹166 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aarti Drugs latest dividend payout ratio is 5.36% and 3yr average dividend payout ratio is 5.15%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech